Tempus AI and Merck Expand Collaboration on AI-Driven Precision Medicine

Tempus AI, Inc. (NASDAQ: TEM) and Merck announced on March 3, 2026 an expanded, multi-year collaboration aimed at accelerating the discovery and development of precision medicine biomarkers and supporting Merck's oncology and potentially broader therapeutic portfolios.

Under the terms of the agreement, Merck will use Tempus' de-identified data along with Tempus' Lens Platform and Workspaces environment, which offers an advanced computational configuration powered by one of the industry's largest GPU infrastructures, which enables researchers to efficiently conduct complex analyses on training-ready multimodal datasets, generating novel insights to accelerate the development and optimization of candidate therapies at scale.

"This collaboration builds on our existing relationship and reflects our shared commitment to harnessing the power of multimodal datasets with AI to deliver better options for patients," said Ryan Fukushima, CEO, Data & Apps at Tempus. "We've spent years configuring our Lens Platform to seamlessly leverage our library of de-identified multimodal data with the necessary AI computing power to train and fine-tune specific models for healthcare."

The Senior Vice President of Discovery, Preclinical Development and Translational Medicine at Merck Research Laboratories stated that the combination of new AI technologies and large curated multimodal data sets are transforming the way the company conducts discovery research. "This collaboration with Tempus positions Merck to advance our precision oncology strategy through the application of the latest AI/ML capabilities to discover novel precision biomarkers, identify mechanisms of cancer cell resistance, and inform rational combinations for drugs in our early pipeline."

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.